Ding, Bin
Wang, Jun
Wei, Xing
Du, Yu
Xia, Liang
Sun, Chenyi
Han, Kun
Yang, Xue
Guo, Xuegang
Pan, Yanglin
Wang, Xiangping
Article History
Received: 21 September 2022
Accepted: 24 November 2022
First Online: 30 November 2022
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki (as revised in 2013). All data are anonymized, images are entirely unidentifiable and no critical details on individuals are reported. This study was approved by the institutional review board of Jiujiang No.1 People's Hospital. The purpose, risk and benefit of endoscopic retrograde cholangiopancreatography was explained and informed consent obtained from all the patients.
: Not applicable.
: The authors declare no conflicts of interest or financial ties.